OSSIO announced that the first surgeons using the OSSIOfiber Interference Screw for ACL reconstruction are Dr. Nirav Amin, Dr. Michael Kaplan, Dr. Nicholas Kennedy, Dr. Justin Newman, Dr. Eric Dockter, and Dr. James Bailey, with Dr. Nirav Amin and Dr. Michael Kaplan serving as design surgeons.
Published
Signal category
Products & Services
Quote
“Congratulations to the first surgeons using the OSSIOfiber® Interference Screw — the first bio-integrative screw designed to deliver stronger fixation and true biological integration in ACL reconstruction.”
— OSSIO team
Company
OSSIO
Only Nature Remains.
- Location
- Woburn, US
- Company size
- 168 employees
Ossio is an orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors. Ossio's mission is to replace metal implants as the standard of care in the $10B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology. OSSIOfiber™ represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore mobility with nothing permanent left behind. Our products have the mechanical strength needed for easy insertion and secure fixation while enabling the body to regrow bone, completely incorporating and replacing the implant without the adverse inflammation and weakness often seen in “bio-resorbables”.